Local or regional breast cancer recurrences mandate adjuvant chemotherapy

Local or regional breast cancer recurrences mandate adjuvant chemotherapy

11/12/2012

SAN ANTONIO, TEXAS—Patients with local or regional recurrences of breast cancer, should be treated with chemotherapy as well as surgery and

SAN ANTONIO, TEXAS—Patients with local or regional recurrences of breast cancer, should be treated with chemotherapy as well as surgery and radiation. That’s according to conclusions from the CALOR (Chemotherapy as Adjuvant for Locally Recurrent breast cancer) study released at the San Antonio Breast Cancer Symposium. Professor Stefan Aebi of the Kantonsspital in Luzern (and the Breast International Group) and Dr Irene Wapnir of Stanford University School of Medicine (representing the National Surgical Adjuvant Breast Project) explain to Peter Goodwin why the issue is now settled.



LISTEN

[audio:https://www.audiomedica.com/podcasting/oncology/121208IreneWapnirStefanAebiPODCASTLoRes.mp3]